Among all breast cancer subtypes, HER2-positive tumors show the highest expression of glutaminase (GLS) and glutamate dehydrogenase (GDH) [43] and overexpression of HER2 in a cell line model directly increases GLS expression [44]. This evidence concerns the gene GLS and breast cancer.